Have a personal or library account? Click to login
The Effect of the Antioxidant Drug U-74389G on Albumin Levels during Ischemia Reperfusion Injury in Rats Cover

The Effect of the Antioxidant Drug U-74389G on Albumin Levels during Ischemia Reperfusion Injury in Rats

Open Access
|Nov 2016

References

  1. 1. https://www.caymanchem.com/app/template/Product.vm/catalog/75860.
  2. 2. Fenglin Shi, Jennifer Cavitt, Kenneth L Audus. 21-aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radical Biology and Medicine, 19(3), 349-357 (1995).10.1016/0891-5849(95)00049-4
  3. 3. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G” on acid phosphatase levels during ischemia reperfusion injury in rats. Appl Med Res. 2016;2(1):1-5.10.5455/amr.20160224103746
  4. 4. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G” on white blood cells levels during hypoxia reoxygenation injury in rats. Asian Journal of Pharmacology and Toxicology. 2016;4(13): 22-32.
  5. 5. Τsompos C, Panoulis C, Τοutouzas K, Ζografos G, Papalois A. Acute Effect Of The Antioxidant Drug “U-74389g” On Hematocrit Levels During Hypoxia and Reoxygenation Injury In Rats. Sci. Med. 2016;26(1): 15-21.
  6. 6. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The acute effect of the antioxidant drug “U-74389G” on red blood cell distribution width levels during hypoxia reoxygenation injury in rats. Folia Medica Пловдив 2015;57(3&4):235-242.10.1515/folmed-2015-0044
  7. 7. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The antioxidant drug“U-74389G” attenuates the mean corpuscular hemoglobin concentration levels during hypoxia reoxygenation injury in rats. JIRMEPS, 9(4): 158-163, 2016
  8. 8. Liepinsh E, Makrecka M, Kuka J, et al: The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 2013 Oct 17. pii: S0026-0495(13)00298-9.
  9. 9. Abubakar S, Sabir A, Ndakotsu M, et al: Low admission serum albumin as prognostic determinant of 30-day case fatality and adverse functional outcome following acute ischemic stroke. Pan Afr Med J. 2013;14:53.
  10. 10. Herisson F, Delaroche O, Auffray-Calvier E, et al: Ischemia-modifi ed albumin and heart fatty acidbinding protein: could early ischemic cardiac biomarkers be used in acute stroke management? J Stroke Cerebrovasc Dis. 2010 Jul-Aug;19(4):279-82.10.1016/j.jstrokecerebrovasdis.2009.07.004
  11. 11. Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, et al: Ischemia-modifi ed albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels. 2008 May;23(3):174-80.10.1007/s00380-007-1031-8
  12. 12. Polk JD, Rael LT, Craun ML, et al: Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia. J Trauma. 2008 Jan;64(1):42-5.10.1097/TA.0b013e31815b846a
  13. 13. Dusek J, Tichý M, Stásek J, et al: Ischemia-modifi ed albumin: new marker of myocardial ischemia?. Cas Lek Cesk. 2005;144(5):295-7; discussion 297.
  14. 14. Worster A, Devereaux PJ, Heels-Ansdell D, et al: Capability of ischemia-modifi ed albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005 Jun 21;172(13):1685-90.10.1503/cmaj.045194
  15. 15. Rafael Sadaba J, Conroy JL, Burniston M, et al: Effect of radial artery harvesting on tissue perfusion and function of the hand. Cardiovasc Surg. 2001 Aug;9(4):378-82.10.1016/S0967-2109(00)00148-4
  16. 16. Steinbauer M, Guba M, Büchner M, et al: Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster. Shock. 2000 Aug;14(2):163-8.10.1097/00024382-200014020-0001510947161
  17. 17. Donaldson GC, Robinson D, Allaway SL. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond). 1997 Mar;92(3):261-8.10.1042/cs09202619093006
  18. 18. Arend SM, Bax JJ, Hermans J, et al: The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Eur Heart J. 1994 Jan;15(1):114-9.10.1093/oxfordjournals.eurheartj.a0603628174570
  19. 19. Pollock DM, Opgenorth TJ. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure. J Pharmacol Exp Ther. 1990 Dec;255(3):1166-9.
  20. 20. Tilton RG, Cole PA, Zions JD, et al: Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits. Circ Res. 1987 Apr;60(4):551-9.10.1161/01.RES.60.4.551
  21. 21. Bagetta G, Palma E, Piccirilli S, et al: Seizures and hippocampal damage produced by dendrotoxin- K in rats is prevented by the 21-aminosteroid U-74389G. Exp Neurol. 1997 Sep;147(1):204-10.10.1006/exnr.1997.65879294417
  22. 22. Tasaka S, Ishizaka A, Urano T, et al: Attenuation of hyperoxic lung injury by the 21-aminosteroid U-74389G. J Appl Physiol (1985). 1995 May;78(5):1635-41.10.1152/jappl.1995.78.5.16357649897
DOI: https://doi.org/10.1515/amb-2016-0012 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 11 - 20
Published on: Nov 23, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 C. Τsompos, C. Panoulis, K. Τοutouzas, A. Triantafyllou, G. Ζografos, A. Papalois, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.